Verition Fund Management Acquires Stake in Semler Scientific, Inc.

Verition Fund Management LLC has acquired a new stake in Semler Scientific, Inc. (NASDAQ:SMLR) during the third quarter, as revealed in the company's recent disclosure to the Securities and Exchange Commission (SEC). The fund purchased 10,645 shares of Semler's stock, which is valued at approximately $251,000. After this acquisition, Verition Fund Management LLC now holds about 0.15% of Semler Scientific based on its latest filing with the SEC.

In addition to Verition Fund Management, several other institutional investors and hedge funds have made changes to their positions in Semler Scientific. For instance, Cerity Partners LLC significantly increased its holdings by 91.5% during the third quarter, bringing its total to 1,345,586 shares, which are valued at around $31.69 million after acquiring an additional 642,982 shares. Similarly, Shariaportfolio Inc. invested in a new position valued at about $3.62 million in the same quarter. Furthermore, AQR Capital Management LLC expanded its stake by 150.1% in the second quarter, now owning 140,498 shares worth approximately $4.83 million after an additional purchase of 84,314 shares.

Additional investments include Crawford Fund Management LLC, which bought a new stake worth about $883,000 in the third quarter, and Dimensional Fund Advisors LP, which lifted its position by 18.3% during the second quarter, now holding 126,177 shares valued at $4.34 million. Overall, institutional investors and hedge funds collectively own approximately 49.37% of Semler Scientific's stock.

Semler Scientific Stock Performance

On Friday, NASDAQ:SMLR opened at $67.17. The company has a market capitalization of $556.77 million, a price-to-earnings (PE) ratio of 32.77, and a beta of 1.18. Its stock has experienced a 50-day simple moving average of $43.82 and a 200-day simple moving average of $34.79. The 52-week range for Semler Scientific’s stock stands between a low of $20.88 and a high of $79.45.

Recently, Semler Scientific reported its quarterly earnings data on November 4th, where it announced earnings per share (EPS) of $0.72, exceeding the analysts' consensus estimate of $0.37 by $0.35. The company generated revenue of $13.51 million during the quarter and reported a net margin of 27.00%, along with a return on equity of 20.31%.

Semler Scientific Overview

Semler Scientific, Inc. specializes in providing innovative technology solutions aimed at enhancing the clinical effectiveness and efficiency of healthcare providers across the United States. One of the key products is QuantaFlo, a rapid four-minute in-office blood flow test that allows healthcare providers to incorporate blood flow measurements into patient assessments of vascular conditions.

investment, stocks, Semler